INCLINE VILLAGE, Nev. , Oct. 8, 2018 /PRNewswire/ --  PDL BioPharma, Inc. ("PDL") (NASDAQ: PDLI) announces the appointment of Edward Imbrogno as Vice President of Finance, a new position.  Mr. Imbrogno brings to PDL more than 30 years of public accounting and financial reporting experience and will

INCLINE VILLAGE, Nev. , Sept. 26, 2018 /PRNewswire/ --  PDL BioPharma, Inc. ("PDL" or the "Company") (NASDAQ: PDLI) announces that John McLaughlin , PDL's chief executive officer, will present at the 2018 Cantor Fitzgerald Global Healthcare Conference in New York City. The session will be webcast

INCLINE VILLAGE, Nev. , Sept. 24, 2018 /PRNewswire/ --  PDL BioPharma, Inc. ("PDL") (NASDAQ: PDLI) announces its Board of Directors has authorized a new stock repurchase program to acquire up to $100 million of the Company's common stock.  Purchases may be made in open-market transactions, in block

INCLINE VILLAGE, Nev. , Aug. 30, 2018 /PRNewswire/ --  PDL BioPharma, Inc. ("PDL" or the "Company") (NASDAQ: PDLI) announces that John McLaughlin , PDL's chief executive officer, will present at the H.C. Wainwright 20 th Annual Global Investment Conference next week in New York City.  The session

INCLINE VILLAGE, Nev. , Aug. 8, 2018 /PRNewswire/ --  PDL BioPharma, Inc. ("PDL" or the "Company") (NASDAQ: PDLI) reports financial results for the three and six months ended June 30, 2018 including: Second Quarter Financial Highlights Total revenues of $46.6 million .

INCLINE VILLAGE, Nev. , Aug. 2, 2018 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL") (NASDAQ: PDLI) announces an amendment to the Royalty Purchase and Sale Agreement (the "Royalty Agreement") with Depomed, Inc. (" Depomed ") under which PDL acquired all of Depomed's remaining rights to royalties and

INCLINE VILLAGE, Nev. , Aug. 1, 2018 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or "the Company") (NASDAQ: PDLI) today announced that the Company will release its second quarter financial results for the period ended June 30, 2018 , on Wednesday, August 8, 2018 , after market close.  PDL's

INCLINE VILLAGE, Nev. , June 22, 2018 /PRNewswire/ --  PDL BioPharma, Inc. ("PDL" or "the Company") (NASDAQ: PDLI) announced today that retired Eli Lilly and Company executive Elizabeth G. O'Farrell has been named to the Company's Board of Directors, effective June 22, 2018 and increasing the

INCLINE VILLAGE, Nev. , June 11, 2018 /PRNewswire/ --  PDL BioPharma, Inc. ("PDL" or "the Company") (NASDAQ: PDLI) announced that at its 2018 annual meeting of stockholders held June 8, 2018 , the Company's stockholders elected Shlomo Yanai to the Company's Board of Directors.  The Company

INCLINE VILLAGE, Nev. , May 21, 2018 /PRNewswire/ --  PDL BioPharma, Inc. ("PDL" or "the Company") (NASDAQ: PDLI) announces the appointment of Jill M. Jene , Ph.D. as Vice President, Business Development . Dr. Jene will lead the efforts to add healthcare assets to PDL's portfolio of products and

INCLINE VILLAGE, Nev. , May 15, 2018 /PRNewswire/ --   PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the company will present at the following two upcoming investor conferences: UBS Global Healthcare Conference Tuesday, May 22, 2018 at 11:30 a.m. EDT New York City Presenter: John P.

INCLINE VILLAGE, Nev. , May 9, 2018 /PRNewswire/ --  PDL BioPharma, Inc. (PDL or the Company) (NASDAQ: PDLI) today reported financial results for the first quarter ended March 31, 2018 including: Total revenues of $38.5 million for the three months ended March 31, 2018 .

INCLINE VILLAGE, Nev. , May 2, 2018 /PRNewswire/ -- PDL BioPharma, Inc. (PDL or the Company) (NASDAQ: PDLI) today announced that it will release its first quarter 2018 financial results for the period ended March 31, 2018 , on Wednesday, May 9, 2018 , after market close.

INCLINE VILLAGE, Nev. , April 16, 2018 /PRNewswire/ -- PDL BioPharma, Inc. (PDL or the Company) (NASDAQ: PDLI) today announced that the Company will hold its annual meeting of stockholders on Friday, June 8, 2018 , at 10:00 a.m. Pacific Time for all stockholders of record on May 4, 2018 .